Blumberg Richard P. bought GTHP
March 26, 2026 · Form 4 insider transaction
Blumberg Richard P. bought 352,000 shares of Guided Therapeutics, Inc., a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4.
Direction
Acquired (buy-side)
Shares
352,000
Price
N/A
Total value
N/A
InsiderBlumberg Richard P.
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeJ: J
Transaction dateMarch 26, 2026
Filing dateMay 5, 2026
Shares owned after10,391,311
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On March 26, 2026, Mr. Blumberg converted 88 shares of Series F-2 preferred stock into 352,000 shares of common stock. The Series F-2 preferred stock had a stated value of $1,000 and $0.25 conversion price.